Second Circuit Revives Safety-Net Providers’ Antitrust Action Against Drug Makers over 340B Discounts
- August 08, 2025
The Second Circuit gave two safety-net providers another chance to allege that four pharmaceutical companies violated federal and state antitrust laws by coordinating to rescind long-standing discounts under the 340B program.
ARTICLE TAGS
You must be logged in to access this content.